Affordable Access

Publisher Website

An update on the safety and efficacy of regorafenib in the treatment of solid cancers.

Authors
Type
Published Article
Journal
Expert opinion on drug metabolism & toxicology
Publication Date
Volume
10
Issue
11
Pages
1607–1614
Identifiers
DOI: 10.1517/17425255.2014.970169
PMID: 25316322
Source
Medline
Keywords
  • Gist
  • Phase I Studies
  • Colorectal Cancer
  • Regorafenib
  • Renal Cell Cancer
  • Toxicity.

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments